127 related articles for article (PubMed ID: 23370422)
21. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
22. Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.
Tarhini A; Ghate SR; Ionescu-Ittu R; Manceur AM; Ndife B; Jacques P; Laliberté F; Nakasato A; Burne R; Duh MS
Melanoma Res; 2018 Dec; 28(6):618-628. PubMed ID: 30216199
[TBL] [Abstract][Full Text] [Related]
23. Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United States.
Klink AJ; Chmielowski B; Feinberg B; Ahsan S; Nero D; Liu FX
J Manag Care Spec Pharm; 2019 Aug; 25(8):869-877. PubMed ID: 30945965
[TBL] [Abstract][Full Text] [Related]
24. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
25. Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting.
Toy EL; Vekeman F; Lewis MC; Oglesby AK; Duh MS
Curr Med Res Opin; 2015 Aug; 31(8):1561-72. PubMed ID: 26086578
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
[TBL] [Abstract][Full Text] [Related]
27. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
[TBL] [Abstract][Full Text] [Related]
28. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
[TBL] [Abstract][Full Text] [Related]
29. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
30. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
31. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
[TBL] [Abstract][Full Text] [Related]
32. Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.
Yang H; Yu AP; Wu EQ; Yim YM; Yu E
J Med Econ; 2011; 14(5):542-52. PubMed ID: 21728912
[TBL] [Abstract][Full Text] [Related]
33. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
34. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
35. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
36. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
37. Survival and cost-effectiveness of hospice care for metastatic melanoma patients.
Huo J; Lairson DR; Du XL; Chan W; Buchholz TA; Guadagnolo BA
Am J Manag Care; 2014 May; 20(5):366-73. PubMed ID: 25181566
[TBL] [Abstract][Full Text] [Related]
38. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
Chen SY; Wu N; Boulanger L; Sacco P
J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
[TBL] [Abstract][Full Text] [Related]
39. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
Ferrari A; Bono A; Baldi M; Collini P; Casanova M; Pennacchioli E; Terenziani M; Marcon I; Santinami M; Bartoli C
Pediatrics; 2005 Mar; 115(3):649-54. PubMed ID: 15741367
[TBL] [Abstract][Full Text] [Related]
40. Cost impact of complications in meningococcal disease: evidence from a United States managed care population.
Davis KL; Misurski D; Miller J; Karve S
Hum Vaccin; 2011 Apr; 7(4):458-65. PubMed ID: 21795848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]